Suppr超能文献

相似文献

2
Rationalising lysozyme amyloidosis: insights from the structure and solution dynamics of T70N lysozyme.
J Mol Biol. 2005 Sep 30;352(4):823-36. doi: 10.1016/j.jmb.2005.07.040.
3
Characterisation of the structural, dynamic and aggregation properties of the W64R amyloidogenic variant of human lysozyme.
Biophys Chem. 2021 Apr;271:106563. doi: 10.1016/j.bpc.2021.106563. Epub 2021 Feb 13.
4
Structural and folding dynamic properties of the T70N variant of human lysozyme.
J Biol Chem. 2003 Jul 11;278(28):25910-8. doi: 10.1074/jbc.M211000200. Epub 2003 Apr 22.
8
Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.
J Mol Biol. 2005 Feb 25;346(3):773-88. doi: 10.1016/j.jmb.2004.11.020. Epub 2004 Nov 24.
9
Local cooperativity in an amyloidogenic state of human lysozyme observed at atomic resolution.
J Am Chem Soc. 2010 Nov 10;132(44):15580-8. doi: 10.1021/ja103524m.
10
Elongation in a beta-structure promotes amyloid-like fibril formation of human lysozyme.
J Biochem. 2002 Oct;132(4):655-61. doi: 10.1093/oxfordjournals.jbchem.a003270.

引用本文的文献

2
SxIP binding disrupts the constitutive homodimer interface of EB1 and stabilizes EB1 monomer.
Biophys J. 2021 May 18;120(10):2019-2029. doi: 10.1016/j.bpj.2021.03.004. Epub 2021 Mar 16.
5
Stable, metastable, and kinetically trapped amyloid aggregate phases.
Biomacromolecules. 2015 Jan 12;16(1):326-35. doi: 10.1021/bm501521r. Epub 2014 Dec 18.
7
Changes in Lysozyme Flexibility upon Mutation Are Frequent, Large and Long-Ranged.
PLoS Comput Biol. 2012;8(3):e1002409. doi: 10.1371/journal.pcbi.1002409. Epub 2012 Mar 1.
9
Dynamics of apomyoglobin in the alpha-to-beta transition and of partially unfolded aggregated protein.
Eur Biophys J. 2009 Feb;38(2):237-44. doi: 10.1007/s00249-008-0375-z. Epub 2008 Oct 14.
10
Ultra-small-sample molecular structure detection using microslot waveguide nuclear spin resonance.
Proc Natl Acad Sci U S A. 2007 May 29;104(22):9198-203. doi: 10.1073/pnas.0703001104. Epub 2007 May 15.

本文引用的文献

1
The CCP4 suite: programs for protein crystallography.
Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3. doi: 10.1107/S0907444994003112.
2
The structural basis of protein folding and its links with human disease.
Philos Trans R Soc Lond B Biol Sci. 2001 Feb 28;356(1406):133-45. doi: 10.1098/rstb.2000.0758.
4
Amyloid diseases: abnormal protein aggregation in neurodegeneration.
Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):9989-90. doi: 10.1073/pnas.96.18.9989.
7
Designing conditions for in vitro formation of amyloid protofilaments and fibrils.
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3590-4. doi: 10.1073/pnas.96.7.3590.
8
Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease.
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3342-4. doi: 10.1073/pnas.96.7.3342.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验